Biotech Innovators and Economic Impact

Biotech Innovators

Economic Impact

Bacterial and parasitic diseases are the second leading causes of death worldwide as said on Time’s website. Biotech companies, or biopharmas, such as Cempra, Bioniche Pharma USA, and GlaxoSmithKline provide products that help treat people with certain bacterial infections. These services were created with the goal to help their patients feel better and strive to restore their health back so that they could continue their everyday lives with effective antibiotics, such as amoxil. Biotechnical researchers are on the case to find more in order to relieve their patients of the health setbacks due to their life threatening diseases.

At Cempra, researchers are trying to find the best products and invention of new studies for the best treatments possible for their patients to live better and stronger. They are currently focused on treating the treats of antibiotic resistant pathogens with their products Solithromycin and fluoro ketolide. They have clinically studied that it was safe and tolerated and well with patients with levofloxacin and pneumonia. They provide treatments of those with moderately severe community acquired pneumonia. It is currently being led by a management team that is involved with drug developments and to provide a future company. Supporters are of disease experts and Scientific Advisory Board. The benefits of using these biotech projects is to help patients who are in need of such medication by their service.http://www.cempra.com/products/

As for Bioniche Pharma USA, they have made new developments on new medicines suited for different patients, like urocidin. Their company is worldwide and have been providing products mostly for the livestock industry. These canadian researchers are technologically driven to discover and develop products in markets with the help of over 200 people. Their company now was three divisions for specific needs such as Animal Health, Human Health, and Bioniche One health. Their investors are the presidents of the company, Jennifer Shea and Brian Ford. Their technological innovations were made to help induce bladder cancer and diseases by studying the designs of the cells such as for MCC suspension. http://www.bioniche.com/aboutus.cfmWhile

at GlaxoSmithKline they are now helping patients with major diseases by help of innovative research by antibiotics, such as on Duchenne muscular dystrophy. GalxoSmithKline is another world wide company that provides people with now medicines and because of their success in improving and producing new antibiotics they have used their technology to help communities on funding support programs in education for medical research and discoveries. They have a board of directors that manage the financial and business of their company.

However, these experiments are usually conducted in small businesses since the outbreak of “superbugs” continue to multiply and endanger people's’ health. These research groups have been funded by the government to induce more technologies, to help better the lives of people. In addition, the Biomedical Advanced Research and Development Authority, or BARDA, a unit of the Department of Health and Human Services, has supported these small companies by giving funds for new medicine.

Overall, these biotechnology companies for the use of antibiotics resulted in mixed reactions towards the consumption of their antibiotics. These reactions towards the medication helps to provide a greater awareness on the effectiveness of certain antibiotics. If there were side effects, users would acknowledge the problems and voice their concern to the companies so that the providers who hold these products to research would find more sustainable medicine for their consumers to use. Consumers help the creation of many new, more sustainable antibiotics that are being produced daily. Antibiotics being developed by biotechnicians for the good of people and responses from these consumers back to the developers maintain a cycle that allow technology for antibiotics to grow.

Image Citation